Political ire around direct contracting that came to a head earlier this year was rooted in a “real lack of understanding,” one CEO of a physician group said Friday at NAACOS’ spring conference.
As it saw a decline in pandemic-related waste, Stericycle experienced its most acute period of driver illnesses yet. The company also previewed a new medical waste facility and closed out a $90 million corruption settlement.
The report calls for improved oversight of MA and urges the CMS to update audit protocols and issue new guidance on medical necessity reviews performed by the plans.
Bristol Myers paid $13 billion to acquire the drug’s maker, MyoKardia, and expects it to become a blockbuster. But a tricky dosing regimen, as well as safety concerns, could challenge the pharmaceutical giant’s lofty forecast.
Wright Lassiter will succeed Lloyd Dean, who announced his intent to retire last year, setting off a nationwide executive search.
The lab and medtech groups joined a coalition of more than 60 organizations warning congressional leaders the funding expiration puts “the most vulnerable” Americans at risk of losing resources to diagnose new infections.
Still, those costs were almost entirely offset by members cutting back on healthcare visits, a common trend throughout the pandemic, CEO Joe Zubretsky said Thursday.
The biotech’s shot would become the first available to children under 6, the last remaining age group currently ineligible for vaccination.
Teladoc bought chronic care giant Livongo for $18.5 billion two years ago, but the asset’s waning value and external market factors triggered the massive goodwill impairment charge in the first quarter.
The payer’s CEO spoke Tuesday about concerns surrounding the implementation of the state’s new Medicaid prescription drug program, following news reports of members struggling to get access and approvals to needed medications.